Hyperion Defi, Inc.
New York, New York, United States · Blockchain, Cryptocurrency, Finance
Eyenovia, Inc. is a pioneering digital ophthalmic technology company and the first U.S. publicly listed company building a long-term strategic treasury of Hyperliquid’s native token, HYPE. With this dual focus, Eyenovia continues to revolutionize topical eye treatment while providing its shareholders with simplified access to the Hyperliquid ecosystem, one of the fastest growing, highest revenue-g
Key facts
- Headquarters
- New York, New York, United States
- Employees
- 13
- Industries
- Blockchain, Cryptocurrency, Finance
- Status
- Public (HYPD)
- Company page
Recent activity at Hyperion Defi, Inc.
- : SEC 8-K (1.02): On September 28, 2026, Hyperion DeFi, Inc. voluntarily repaid in full all outstanding obligations under the Loan and Security Agreement with Avenue Capital Management II, L.P., thus terminating the agreement. This Loan Agreement, which was initially set for up to $15.0 million in term loans, has been completely settled, resulting in the termination of all related documents and release of any liens on the company's assets. The decision to repay the loan indicates a shift in the company's financial strategy, suggesting improved liquidity or a reduced need for outside financing.
- : SEC 8-K (7.01): On August 12, 2026, Hyperion Defi, Inc. announced a conference call to discuss its financial and operating results for the quarter ended June 30, 2026. The call will feature an investor presentation, which has been furnished as Exhibit 99.2 in the filing. This disclosure is intended for transparency regarding the company's performance and does not constitute a formal filing under certain provisions of the Securities Act. The issuance of this information is significant as it allows stakeholders to gain insights into the company’s financial health and strategic direction.
- : SEC 8-K (5.02): Effective July 7, 2026, the Company entered into new employment agreements with key executive officers including Hyunsu Jung, the CEO, David Knox, the CFO, and Robert Rubenstein, the General Counsel. These agreements aim to align executive compensation with industry best practices and ensure consistency among the executives. The agreements specify severance benefits in cases of termination without cause or for good reason following a change in control, offering benefits such as accrued obligations, base salary for 12 months, and health insurance continuity. Additionally, any time-based vesting conditions for equity awards will be deemed satisfied upon a change in control while they remain employed.
- : SEC 8-K (8.01):
- : SEC 8-K (8.01): On May 13, 2026, Hyperion Defi, Inc. issued 132,249 shares of its common stock to Chardan Capital Markets, LLC, who exercised a 30-day option under a previously announced Underwriting Agreement dated May 5, 2026. This transaction resulted in approximately $0.4 million in net proceeds for the Company. The event indicates a capital-raising effort by the Company, potentially to enhance liquidity or support ongoing operations. The Underwriting Agreement allows for a total purchase option of up to 416,666 shares, signaling ongoing engagement with investors and market support.
- : SEC 8-K (8.01): On May 5, 2026, Hyperion DeFi, Inc. entered into an underwriting agreement with Chardan Capital Markets, LLC for the issuance and sale of 2,777,778 shares of the Company's common stock at an offering price of $3.60 per share. The Underwriter will purchase these shares at $3.384 each, potentially generating net proceeds of approximately $8.7 million, or $10.1 million if the Underwriter's 30-day option to purchase an additional 416,666 shares is exercised. The offering is set to close on May 7, 2026, pending customary closing conditions, and is being made under the Company's shelf registration statement. This transaction reflects substantial strategic financing for the Company with potential implications for capital structure and market positioning.
- : SEC 8-K (7.01): On March 26, 2026, Hyperion DeFi, Inc. announced through a Regulation FD Disclosure that it will host a conference call to discuss its financial and operating results from the year ended December 31, 2025. This call will also feature an investor presentation, which is included as Exhibit 99.2 in the filing. The presentation outlines key financial metrics and strategic insights from the prior year, aimed at informing investors about the company's performance and future outlook. The disclosure is part of the company's ongoing commitment to transparency and investor relations.
- : Hyperion DeFi Appoints Hyunsu Jung as Chief Executive Officer
- : SEC 8-K (5.02): On January 1, 2026, Hyunsu Jung was appointed as the permanent Chief Executive Officer of the Company, after serving as the Interim CEO since September 2025. The Board of Directors made this decision effective immediately, highlighting Mr. Jung's experience as both a director and Chief Investment Officer at the Company since June 2025. His amended employment agreement stipulates a base salary of $520,000, eligibility for performance-based cash bonuses up to 100% of his salary, and conditions for potential termination of employment. This appointment is significant for the Company's leadership stability and strategic direction as they approach their annual meeting of stockholders in 2026.
- : SEC 8-K (8.01):
Hyperion Defi, Inc. funding history
| Date | Round | Amount |
|---|---|---|
| Jun 2025 | Post-IPO Equity | $50.0M |
| Apr 2020 | Venture | $6.0M |
| Aug 2017 | Venture | $6.0M |
| Aug 2016 | Seed | $4.0M |
Leadership
- SHUHEI YOSHIDA, Director
- ERNEST MARIO, Director
- FRED ESHELMAN, Director
- CURT LABELLE, Executive Officer, Director
- TSONTCHO IANCHULEV, Executive Officer, Director
- Hyunsu Jung, Chief Executive Officer
- David Knox, Chief Financial Officer
Verified email and direct lines for Hyperion Defi, Inc.’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Hyperion Defi, Inc. files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Companies similar to Hyperion Defi, Inc.
- Nakamoto · Blockchain, Cryptocurrency, Finance, Financial Services, Fintech, Healthcare, Health Care, Lending
- Evernorth · Blockchain, Cryptocurrency, Finance, Financial Services, Fintech, Health Care, Lending
- Ensysce Biosciences · Finance, Financial Services, Fintech, Healthcare, Lending, Manufacturing
- AGI3 · Blockchain, Cryptocurrency, Finance, Financial Services, Fintech, Lending
- Silvia, Inc. · Blockchain, Cryptocurrency, Finance, Financial Services, Fintech, Lending
About Hyperion Defi, Inc.: questions and answers
What does Hyperion Defi, Inc. do?
Eyenovia, Inc. is a pioneering digital ophthalmic technology company and the first U.S. publicly listed company building a long-term strategic treasury of Hyperliquid’s native token, HYPE. With this dual focus, Eyenovia continues to revolutionize topical eye treatment while providing its shareholders with simplified access to the Hyperliquid ecosystem, one of the fastest growing, highest revenue-g
Where is Hyperion Defi, Inc. headquartered?
Hyperion Defi, Inc. is headquartered in New York, New York, United States.
How many employees does Hyperion Defi, Inc. have?
Hyperion Defi, Inc. has about 13 employees.
Has Hyperion Defi, Inc. raised funding?
Yes. Fundz has recorded 4 funding events for Hyperion Defi, Inc.. The most recent, Post-IPO Equity of $50.0M, was in Jun 2025.
Who leads Hyperion Defi, Inc.?
Hyunsu Jung is a Chief Executive Officer at Hyperion Defi, Inc..
What is the latest news on Hyperion Defi, Inc.?
On Sep 28, 2026, SEC 8-K (1.02): On September 28, 2026, Hyperion DeFi, Inc. voluntarily repaid in full all outstanding obligations under the Loan and Security Agreement with Avenue Capital Management II, L.P., thus terminating the agreement. This Loan Agreement, which was initially set for up to $15.0 million in ter
Is Hyperion Defi, Inc. a public company?
Yes. Hyperion Defi, Inc. is publicly traded under the ticker HYPD.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy